Close Menu

NEW YORK – Invitae is selling $300 million in convertible senior notes in a private offering. 

The company increased the offering size from the previously announced $200 million and granted initial purchasers of the notes a 13-day option to purchase an additional $50 million worth of notes under the same terms and conditions. Invitae is expecting net proceeds of $291.2 million or $339.8 million if purchasers exercise the option to buy additional notes. 

The sale is slated to close on Sept. 10. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.